• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » GE HealthCare clears one of the final hurdles to going independent

GE HealthCare clears one of the final hurdles to going independent

December 1, 2022 By Sean Whooley

GE HealthCare's new logoGE (NYSE:GE) announced that its board of directors approved the previously announced spinoff of its GE HealthCare business.

Prior to the spinoff, GE expects GE HealthCare to convert into a corporation named GE HealthCare Technologies Inc. It anticipates trading for the company to begin on the Nasdaq market on Jan. 4, 2023, under the “GEHC” ticker. The company registered a Form 10 statement with the SEC last month with the expectation of the spinoff completing at the start of 2023.

To effect the separation of businesses, GE’s board approved a distribution to shareholders of at least 80.1% of GE HealthCare’s outstanding shares. Holders of GE common stock are entitled to receive one share of GEHC common stock for every three shares of GE common stock held on Dec. 16, 2022. GE expects the distribution to occur after market close on Jan. 3, 2023.

Effective upon the spinoff, GE plans to retain 19.9% of the outstanding shares of GEHC common stock. GE shareholders don’t need to take action to receive shares of GEHC common stock. They don’t need to pay any consideration or surrender or exchange shares of GE common stock to participate.

“Today’s announcement marks one of the final milestones for our planned spin-off of GE HealthCare as we move toward launching three independent, industry-leading, and investment-grade companies,” said GE Chair and CEO H. Lawrence Culp, Jr. “GE Healthcare is driving precision care globally, with a clear strategy for value creation that will benefit patients, customers, and shareholders under the leadership of CEO Peter Arduini and his team.”

Last week, GE announced that GE HealthCare closed an offering of senior notes worth $8.5 billion. The company earlier this month announced the offering in connection with the planned spinoff.

Filed Under: Business/Financial News, Featured, News Well, Wall Street Beat Tagged With: GE Healthcare

More recent news

  • Medtronic nets CE mark for Vitalis family of conduction system pacemakers
  • E2’s pulmonary embolism platform claims two FDA clearances
  • Resmed to launch AirTouch F40 full-face fabric CPAP mask in US
  • Paradromics taps Siemens Healthineers to develop scalable BCI imaging
  • THL Partners’ new hire to target medtech, life sci tool developers

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy